Actively Recruiting
Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
Led by Xijing Hospital · Updated on 2024-07-29
200
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore an effective noninvasive method for differential diagnosis of liver tumors.
CONDITIONS
Official Title
Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 70 years
- Liver examination performed before ultrasound-guided liver biopsy or surgery
- Tumor visible on conventional ultrasound imaging
- Largest tumor section saved in DICOM format for analysis
- Histopathological diagnosis from biopsy or surgical resection
- Clinical and ultrasound data available within 7 days of diagnosis
You will not qualify if you...
- No available pathological diagnosis
- Presence of liver metastatic tumors
- Poor quality ultrasound images
- History of liver surgery, local ablation, radiation, transarterial or systemic therapies, or liver transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xijing Hosptial
Xi'an, Xi'an, China, 710032
Actively Recruiting
Research Team
Z
Zhou Huihui, M.M.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here